CRISPR is one of the most powerful discoveries of the last decade.

In a remarkably short space of time, ‘classic’ CRISPR-Cas9 has established itself as a reliable tool in the genomics toolbox, which leads to the question: what’s next?

CRISPR 2.0 is the industry-leading meeting dedicated to answering this question by showcasing only the latest and greatest innovations in CRISPR technology, from the potential of prime editing through to epigenome editing to treat chronic pain.

Don’t get left behind. Join leading pharma and biotech companies pioneering CRISPR-based therapeutics into the clinic and academic organizations breaking new ground in establishing novel CRISPR tools.

Join us to usher in the next generation of safe, targeted and effective genome editing.